Geriatric nutritional risk index predicts all-cause mortality in patients with heart failure: A systematic review and

Chao-Hui Dong1, Si-Yu Chen2, Hong-Lian Zeng1

  • 1Department of Health Management Center, Affiliated Hospital of Chengdu University, Jinniu district, Chengdu City, Sichuan Province, China.

Insights

The Geriatric Nutritional Risk Index (GNRI) effectively predicts all-cause mortality in heart failure (HF) patients. Lower GNRI scores indicate a significantly higher risk of mortality in this population.

Area of Science:

  • Geriatric Medicine
  • Cardiology
  • Nutritional Science

Background:

  • Heart failure (HF) is a complex condition with high mortality rates.
  • Nutritional status is increasingly recognized as a critical factor in HF patient outcomes.
  • The Geriatric Nutritional Risk Index (GNRI) is a validated tool for assessing nutritional status in older adults.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the association between the Geriatric Nutritional Risk Index (GNRI) and all-cause mortality in patients with heart failure (HF).
  • To synthesize evidence from multiple studies to provide a robust estimate of GNRI's predictive value for mortality in HF.

Main Methods:

  • Systematic literature search of major databases including PubMed, Medline, Cochrane Library, and Embase.
  • Inclusion of nine studies comprising 7,659 patients with heart failure.
  • Meta-analysis focused on all-cause mortality as the primary endpoint.

Main Results:

  • A GNRI below 92 (major/moderate risk) was significantly associated with increased all-cause mortality in elderly HF patients (HR 1.59, 95% CI 1.37-1.85).
  • A GNRI below 98 (low risk) also predicted increased all-cause mortality compared to higher GNRI values (HR 1.56, 95% CI 1.12-2.18).
  • Subgroup analysis suggested that the GNRI-mortality relationship may vary depending on HF subtype.

Conclusions:

  • The Geriatric Nutritional Risk Index (GNRI) is a simple, well-established tool for predicting all-cause mortality in heart failure patients.
  • GNRI serves as a valuable prognostic indicator in the management of elderly individuals with HF.
  • Nutritional assessment using GNRI can aid in risk stratification and potentially guide interventions in HF care.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
90
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
126
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
70
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
76
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
68
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
222